Anna Eshoo: “This should not be a partisan issue--it is simply the right thing to do.”

I see, as I expressed to you when we spoke, a disconnect between CMS, the FDA, and the VA on new treatments for mild Alzheimer's.

Simply put, we are not getting the best value for our healthcare dollar.

I think that the committee needs to take that into consideration.

The Republican majority's actions are inconsistent with their calls for bipartisan collaboration.